Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VEEV · against 58 other Healthcare companies of similar size
Ranked #18 of 59 · scores higher than 71% of peers
Bars: peers in each 10-point band of the growth score7 peers with a growth score of 60–69, including VEEV · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
| Metric | VEEV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 59 reported | 16.5% | 9.9% | 79% | 33% | |
| Earnings per share growthHigher is better · 47 reported | 26.8% | 12.7% | 70% | 33% | |
| 3-year revenue growthHigher is better · 59 reported | 15.7% | 6.5% | 83% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 56.7B USD | 96 | 79 | |
| 2 | 40.2B USD | 92 | 73 | |
| 3 | 4.61T JPY (≈$31.3B) | 89 | 76 | |
| 4 | 43.30T KRW (≈$31.2B) | 86 | 68 | |
| 4 | 56.0B USD | 86 | 39 | |
| 14 | 540.4B BRL (≈$97.3B) | 72 | 64 | |
| 14 | 97.5B USD | 72 | 67 | |
| 16 | 27.8B USD | 71 | 55 | |
| 16 | 45.2B USD | 71 | 46 | |
| 18 | 49.1B USD | 69 | 69 | |
| 19 | 34.6B USD | 68 | 58 | |
| 20 | 327.3B CNY (≈$45.8B) | 64 | 75 | |
| 20 | 78.1B USD | 64 | 60 | |
| 22 | 8.24T JPY (≈$56.0B) | 63 | 75 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score